PET/CT

Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

PET scans offer insight into how ketamine affects depression
Thanks to a newly developed radiotracer and PET imaging, experts believe they may have unearthed new insights on the drug's impact.
Combining PET and MRI data may be key to differentiating new type of dementia
Limbic-predominant age-related TDP-43 encephalopathy, also known as LATE, was recently recognized as a type of dementia that occurs in older adults. It typically presents as memory-related cognitive decline.
Side effect of popular Alzheimer's treatment may actually be a good sign, new PET findings suggest
Amyloid-related imaging abnormality edema is a known side effect of anti-amyloid monoclonal antibody treatments, such as Leqembi and donanemab Kisunla.
Drugmaker expands manufacturing of popular prostate PET imaging agent
The move will make the Huntsman Cancer Institute the first academic medical center in the U.S. to produce Posluma, according to Blue Earth Diagnostics.
FDA clears new PET/MRI combo system from Siemens Healthineers
The Biograph One is the company's second-generation PET/MRI combo scanner—its first in 14 years.

PET/MR findings in long COVID patients linked to long-term cardiopulmonary diseases

Experts suggest abnormal findings on cardiopulmonary PET/MR should be considered a risk factor for long-term complications in COVID patients.

doctor comparing the costs of different medical treatments

Post-ablation PET imaging may not be cost-effective in patients with liver metastases

Although most radiology organizations agree that [18F]FDG PET/CT can provide valuable information in these patients post-treatment, their recommendations differ on its use.

Mayo Clinic develops AI capable of substantially improving dementia diagnoses

With the software's help, readers are up to three times more accurate and interpretations are nearly twice as fast.

FDA approves expanded use of PET imaging agent

The product's updated indications include quantification and long-term monitoring of amyloid plaques on imaging.

'Powerful' new PET agent improves the diagnosis of triple-negative breast cancer

The agent “exhibits powerful tumor delineation” in challenging cases of determining cancer subtypes, and could potentially lead to more personalized, effective treatment strategies.

Industry partnership set to advance research on theranostics

The deal will create a Therapy Command Center to support the study and use of theranostics across Massachusetts General Hospital and its affiliated centers in bordering states.

SNMMI unveils its 2025 Image of the Year

The designation was awarded to a research team from China, who analyzed the efficacy of a novel radiotracer developed to target expression of the PD-L1 protein in suspected head and neck cancers.

Tau tangles on PET scans may signal impending cognitive decline in asymptomatic individuals

New data highlight the significance of tau-positive imaging in the progression of Alzheimer’s disease.

PET/CT

PET scans offer insight into how ketamine affects depression

Combining PET and MRI data may be key to differentiating new type of dementia

Side effect of popular Alzheimer's treatment may actually be a good sign, new PET findings suggest

Drugmaker expands manufacturing of popular prostate PET imaging agent

FDA clears new PET/MRI combo system from Siemens Healthineers